These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15987993)

  • 1. Current treatments and promising investigations in a multidisciplinary setting.
    Vokes E
    Ann Oncol; 2005; 16 Suppl 6():vi25-vi30. PubMed ID: 15987993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?
    Bourhis J; Lefebvre JL; Vermorken JB
    Eur J Cancer; 2010 Jul; 46(11):1979-89. PubMed ID: 20561781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy or chemoradiotherapy in head and neck cancer.
    Jain P; Kumar P; Pai VR; Parikh PM
    Indian J Cancer; 2008; 45(3):83-9. PubMed ID: 19018109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Attempts to improve organ preservation in patients with squamous cell carcinoma of the head and neck].
    Taguchi T; Tsukuda M
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2030-4. PubMed ID: 16352924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Evolving and Future Role of Taxanes in Squamous Cell Carcinomas of the Head and Neck: A Review.
    Mody MD; Gill HS; Saba NF
    JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):898-905. PubMed ID: 27389786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck.
    Awada A; Ismael G
    Curr Opin Oncol; 2007 May; 19(3):177-9. PubMed ID: 17414633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising new advances in head and neck radiotherapy.
    Harari PM
    Ann Oncol; 2005; 16 Suppl 6():vi13-vi19. PubMed ID: 15987991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel in the management of patients with head and neck squamous cell carcinoma.
    Bernier J; Vrieling C
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1023-32. PubMed ID: 18588449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy for head and neck cancer: recent data.
    Vokes EE
    Oncologist; 2010; 15 Suppl 3():3-7. PubMed ID: 21036882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum.
    Brizel DM; Esclamado R
    J Clin Oncol; 2006 Jun; 24(17):2612-7. PubMed ID: 16763273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding role of the medical oncologist in the management of head and neck cancer.
    Choong N; Vokes E
    CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti EGFR therapy in the treatment of non-metastatic head and neck squamous cell carcinoma: The current evidence.
    Benson R; Mallick S; Julka PK; Rath GK
    J Egypt Natl Canc Inst; 2016 Sep; 28(3):141-8. PubMed ID: 27160750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Schultz JD; Bran G; Anders C; Sadick H; Faber A; Hörmann K; Sauter A
    Oncol Rep; 2010 Nov; 24(5):1213-6. PubMed ID: 20878112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy: to use or not to use? That is the question.
    Brizel DM; Vokes EE
    Semin Radiat Oncol; 2009 Jan; 19(1):11-6. PubMed ID: 19028340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?
    Bernier J; Schneider D
    Eur J Cancer; 2007 Jan; 43(1):35-45. PubMed ID: 17098420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts of management in radiotherapy for head and neck squamous-cell cancer.
    Mazeron R; Tao Y; Lusinchi A; Bourhis J
    Oral Oncol; 2009; 45(4-5):402-8. PubMed ID: 19375379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck.
    Biete Solà A; Marruecos Querol J; Calvo Manuel FA; Verger Fransoy E; Rovirosa Casino A; Grau de Castro JJ; de Las Heras González M; Ramos Aguerri A; Palacios Eito A; Veiras Candal C; Solano López MV
    Clin Transl Oncol; 2007 Apr; 9(4):244-50. PubMed ID: 17462977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of chemotherapy in locally advanced head and neck squamous cell carcinoma.
    Nwizu T; Ghi MG; Cohen EE; Paccagnella A
    Semin Radiat Oncol; 2012 Jul; 22(3):198-206. PubMed ID: 22687944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.